Technology
Health
Biotechnology

Pfenex

$7.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.13 (1.87%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Pfenex and other stocks, options, ETFs, and crypto commission-free!

About

Pfenex Inc., also called Pfenex, is a clinical-stage biotechnology company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes biosimilars and vaccines. Read More The company was founded on November 19, 2009 and is headquartered in San Diego, CA.

Employees
71
Headquarters
San Diego, California
Founded
2009
Market Cap
218.92M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
145.72K
High Today
$7.18
Low Today
$6.80
Open Price
$6.95
Volume
19.87K
52 Week High
$7.40
52 Week Low
$3.13

Collections

Technology
Health
Biotechnology
Medical
Pharmaceutical
2014 IPO
US
North America

News

Seeking AlphaMay 13

Pfenex: The First U.S. Forteo Biosim And A Host Of Other Biosims In Pipeline

Using the 351(k) and the 505(b)(2) pathways, Pfenex (NYSEMKT:PFNX) develops biosimilars of major drugs that are going off-patent.

45
Seeking AlphaMay 11

Pfenex's CEO Eef Schimmelpennink on Q1 2019 Results - Earnings Call Transcript

Pfenex, Inc. (NYSEMKT:PFNX) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Eef Schimmelpennink – Chief Executive Officer Susan Knudson – Chief Financial Officer Conference Call Participants Jason Butler – JMP Securities Andy Hsieh – William Blair Roy Buchanan – JMP Securities Operator Greetings, ladies and gentlemen, and welcome to the Pfenex First Quarter 2019 Results and Business Update Call. A brief question-and-answer session will follow the formal presentation. As...

12
Yahoo FinanceMay 9

Pfenex Reports Q1 Loss, Tops Revenue Estimates

Pfenex (PFNX) delivered earnings and revenue surprises of 52.00% and 84.05%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

12

Earnings

-$0.56
-$0.30
-$0.03
$0.23
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.